PEN Q1 2020 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$137M+6.9% YoY

Gross Profit

$88M64.1% margin

Operating Income

$610,0000.4% margin

Net Income

$1M1.0% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$664M

Total Liabilities

$176M

Stockholders' Equity

$489M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$137M	$128M	+6.9%
Gross Profit	$88M	$84M	+4.9%
Operating Income	$610,000	$11M	-94.5%
Net Income	$1M	$11M	-86.7%

Revenue Segments

Neuro

$78M57%

Peripheral Vascular

$59M43%

Geographic Segments

UNITED STATES

$96M70%

Other Non-US

$42M30%